Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 09, 2022 18:10 ET | Source: Statera Biopharma

Statera Biopharma Announces Closing of $2.0 Million Registered Direct Offering

FORT COLLINS, Colo., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (NASDAQ: STAB) (the “Company” or “Statera Biopharma”), a leading biopharmaceutical company creating next-generation...
February 06, 2022 22:59 ET | Source: Statera Biopharma

Statera Biopharma Announces Pricing of $2.0 Million Registered Direct Offering

FORT COLLINS, Colo., Feb. 06, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (NASDAQ: STAB) (the “Company” or “Statera Biopharma”), a leading biopharmaceutical company creating next-generation...
December 29, 2021 07:32 ET | Source: Statera Biopharma

Statera Biopharma Submits Phase 3 Clinical Trial Protocol to FDA for Investigational Treatment of Pediatric Crohn’s Disease

FORT COLLINS, Colo., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune...
December 20, 2021 16:03 ET | Source: Statera Biopharma

Statera Biopharma Announces First Patient Dosed in Study of STAT-205 for Acute COVID

Initial Study to Evaluate Pharmacokinetics, Biomarkers and Safety of STAT-205 Targeting Preliminary Data 2022 FORT COLLINS, Colo., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq:...
December 01, 2021 07:32 ET | Source: Statera Biopharma

Statera Biopharma Announces FDA Lifts Clinical Hold on Entolimod

FORT COLLINS, Colo., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune...
November 15, 2021 16:03 ET | Source: Statera Biopharma

Statera Biopharma Provides Third Quarter 2021 Financial and Corporate Update

FORT COLLINS, Co., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune...
November 09, 2021 07:32 ET | Source: Statera Biopharma

Statera Biopharma, Inc. to Report Third Quarter 2021 Financial Results

FORT COLLINS, Colo., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune...
November 01, 2021 07:32 ET | Source: Statera Biopharma

Statera Biopharma Honors Pancreatic Cancer Awareness Month

FORT COLLINS, Colo., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune...
October 19, 2021 07:32 ET | Source: Statera Biopharma

Statera Biopharma, Inc. Announces Institutional Review Board Approves Study of STAT-205 for Acute COVID-19

Researchers at Loma Linda University Health to Evaluate Pharmacokinetics, Biomarkers and Safety of STAT-205 FORT COLLINS, Colo., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq:...
October 06, 2021 07:33 ET | Source: Statera Biopharma

Statera Biopharma, Inc. to Participate in the A.G.P. Biotech and Specialty Pharma Conference

FORT COLLINS, Colo., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune...